lescol xl 80 mg prolonged-release tablets
novartis ireland limited - fluvastatin - prolonged-release tablet - 80 milligram(s) - hmg coa reductase inhibitors; fluvastatin
lescol xl 80 mg prolonged-release tablets
ethyx pharmaceuticals - fluvastatin - prolonged-release tablet - hmg coa reductase inhibitors; fluvastatin
lescol xl 80 mg prolonged-release tablets
ltt pharma limited - fluvastatin sodium - prolonged-release tablet - 80 milligram(s) - hmg coa reductase inhibitors; fluvastatin
lescol
novartis new zealand ltd - fluvastatin sodium 21.06mg equivalent to fluvastatin 20 mg - capsule - 20 mg - active: fluvastatin sodium 21.06mg equivalent to fluvastatin 20 mg excipient: calcium carbonate gelatin iron oxide red iron oxide yellow magnesium stearate maize starch microcrystalline cellulose purified talc sodium bicarbonate tekprint red sw-1102 titanium dioxide - adults as an adjunct to diet for the reduction of elevated total cholesterol (total-c), low-density lipoprotein cholesterol (ldl-c), apolipoprotein b (apo b) and triglycerides (tg) levels and for the increase of high-density lipoprotein cholesterol (hdl-c) in adults with primary hypercholesterolaemia and mixed dyslipidaemia (fredrickson types iia and iib). paediatric population as an adjunct to diet for the reduction of elevated total-c, ldlc, apo b and tg levels and for the increase of hdl-c in children and adolescents aged 9 years and older with heterozygousfamilial hypercholesterolaemia.
lescol
novartis new zealand ltd - fluvastatin sodium 42.12mg equivalent to fluvastatin 40 mg - capsule - 40 mg - active: fluvastatin sodium 42.12mg equivalent to fluvastatin 40 mg excipient: calcium carbonate gelatin iron oxide red iron oxide yellow magnesium stearate maize starch microcrystalline cellulose purified talc sodium bicarbonate tekprint red sw-1102 titanium dioxide - adults as an adjunct to diet for the reduction of elevated total cholesterol (total-c), low-density lipoprotein cholesterol (ldl-c), apolipoprotein b (apo b) and triglycerides (tg) levels and for the increase of high-density lipoprotein cholesterol (hdl-c) in adults with primary hypercholesterolaemia and mixed dyslipidaemia (fredrickson types iia and iib). paediatric population as an adjunct to diet for the reduction of elevated total-c, ldlc, apo b and tg levels and for the increase of hdl-c in children and adolescents aged 9 years and older with heterozygousfamilial hypercholesterolaemia.
vastin
astrazeneca limited - fluvastatin sodium 21.06mg equivalent to fluvastatin 20 mg; - capsule - 20 mg - active: fluvastatin sodium 21.06mg equivalent to fluvastatin 20 mg excipient: calcium carbonate gelatin iron oxide red iron oxide yellow magnesium stearate maize starch microcrystalline cellulose purified talc shellac sodium bicarbonate titanium dioxide
vastin
astrazeneca limited - fluvastatin sodium 42.12mg equivalent to fluvastatin 40 mg; - capsule - 40 mg - active: fluvastatin sodium 42.12mg equivalent to fluvastatin 40 mg excipient: calcium carbonate gelatin iron oxide red iron oxide yellow magnesium stearate maize starch microcrystalline cellulose purified talc shellac sodium bicarbonate titanium dioxide
lescol 40 mg hard caps.
novartis pharma sa-nv - fluvastatin sodium 42,12 mg - eq. fluvastatin 40 mg - capsule, hard - 40 mg - fluvastatin sodium 42.12 mg - fluvastatin
lescol 20 mg hard caps.
novartis pharma sa-nv - fluvastatin sodium 21,06 mg - eq. fluvastatin 20 mg - capsule, hard - 20 mg - fluvastatin sodium 21.06 mg - fluvastatin
lescol-exel 80 mg tabl. prol.-rel.
ethyx pharmaceuticals sasu - fluvastatin sodium 84,24 mg - eq. fluvastatin 80 mg - prolonged-release tablet - 80 mg - fluvastatin sodium 84.24 mg - fluvastatin